Antisense inhibition of ptp1b expression
CA 2397590 C · Owner: Cowsert, Lex M. · Inventors: Wyatt, Jacqueline R.; Cowsert, Lex M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Antisense compounds, compositions and methods are provided for inhibiting the expression of PTP1B. The compositions comprise antisense compounds particularly antisense oligonucleotides targeted to nucleic acids encoding , PTP1B. Methods of using these compounds for inhibition of PTP1B expression and for treatment of diseases associated with expression of PTP1B are provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 4, 2001 and granted August 16, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 4, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 4, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.